Volume 9, Issue 2 (6-2021)                   Jorjani Biomed J 2021, 9(2): 1-4 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khorasani M, Alaie M, Shojaee M. Role of Aberrant Alternative Splicing in Cancer. Jorjani Biomed J. 2021; 9 (2) :1-4
URL: http://goums.ac.ir/jorjanijournal/article-1-753-en.html
1- Department of Biochemistry and nutrition, School of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran , khorasani.m@gmu.ac.ir
2- Department of Clinical Biochemistry, Tarbiat Modares University, Tehran, Iran
3- Department of Biology, Payame Noor University of Mashhad, Iran
Abstract:   (424 Views)
Alternative splicing can alter genome sequence and as a consequence, many genes change to oncogenes. This event can also affect protein function and diversity. The growing number of study elucidate the pathological influence of impaired alternative splicing events on numerous disease including cancer. Here, we would like to highlight the significant role of alternative splicing in cancer biology and emphasize the necessity for conducting more research into target alternative splicing as a treatment for cancer.
Full-Text [PDF 302 kb]   (112 Downloads) |   |   Full-Text (HTML)  (111 Views)  
95% of human genes transcribe more than one transcript and generate variant protein isoforms tumors have irregular splicing pattern alternative splicing process are common occurrence and can be used as novel therapeutic biomarkers.
Type of Article: Letter to Editor | Subject: Molecular Sciences
Received: 2021/03/15 | Accepted: 2021/04/1 | Published: 2021/06/10

References
1. Mohammadoo Khorasani M, Karami Tehrani F, Parizadeh SMR, Atri M. Differential expression of alternative transcripts of soluble guanylyl cyclase, GYCY1a3 and GUCY1b3 genes, in the malignant and benign breast tumors. Nitric Oxide. 2019:65-71. [view at publisher] [DOI] [Google Scholar]
2. Barberán-Soler S, Ragle JM. Alternative splicing regulation of cancer-related pathways in Caenorhabditis elegans: an in vivo model system with a powerful reverse genetics toolbox. Int J Cell Biol. 2013;2013. [view at publisher] [DOI] [Google Scholar]
3. Pleiss JA, Whitworth GB, Bergkessel M, Guthrie C. Rapid, transcript-specific changes in splicing in response to environmental stress. Mol Cell. 2007;27(6):928-37. [view at publisher] [DOI] [Google Scholar]
4. Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev. 2003;17(4):419-37. [view at publisher] [DOI] [Google Scholar]
5. David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 2010;463(7279):364-8. [view at publisher] [DOI] [Google Scholar]
6. Biamonti G, Bonomi S, Gallo S, Ghigna C. Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT). Cell Mol Life Sci. 2012;69(15):2515-26. [view at publisher] [DOI] [Google Scholar]
7. Liu J, Lee W, Jiang Z, Chen Z, Jhunjhunwala S, Haverty PM, et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res. 2012;22(12):2315-27. [view at publisher] [DOI] [Google Scholar]
8. Venables JP. Unbalanced alternative splicing and its significance in cancer. Bioessays. 2006;28(4):378-86. [view at publisher] [DOI] [Google Scholar]
9. Ladomery M. Aberrant alternative splicing is another hallmark of cancer. Int J Cell Biol. 2013;2013. [view at publisher] [DOI] [Google Scholar]
10. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nature Reviews Cancer. 2013;13(2):97-110. [view at publisher] [DOI] [Google Scholar]
11. Warzecha CC, Carstens RP, editors. Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). Semin Cancer Biol; 2012: Elsevier. [view at publisher] [DOI] [Google Scholar]
12. Sharma S, Liao W, Zhou X, Wong DT, Lichtenstein A. Exon 11 skipping of E-cadherin RNA downregulates its expression in head and neck cancer cells. Mol Cancer Ther. 2011;10(9):1751-9. [view at publisher] [DOI] [Google Scholar]
13. Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, et al. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. The Journal of clinical investigation. 2011;121(3):1064-74. [DOI] [Google Scholar]
14. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 2005;436(7047):123-7. [view at publisher] [DOI] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2021 CC BY-NC 4.0 | Jorjani Biomedicine Journal

Designed & Developed by : Yektaweb